abstract |
The present invention is directed to aziridinyl epothilone compounds as further described herein, and/or pharmaceutically-acceptable salts and/or solvates thereof having Formula (X). The compounds can be used in cancer treatment of for the preparation of conjugates for targeted drug delivery, especially folates. |